The learning objectives for this conference are based on knowledge gaps identified by experts in the prostate cancer field. Upon completion of this program, participants will be able to:
- Assess how to properly identify and classify patients in all stages of prostate cancer, from active surveillance to advanced disease, incorporating a holistic understanding of patient care including caregiver perspectives.
- Define the roles of genetic testing, molecular imaging, genomics, and artificial intelligence in prostate cancer decision-making—from initial screening through advanced disease—while examining biomarkers, genomic interpretation, and strategies for treatment deintensification.
- Examine state-of-the-art therapies for clinically localized and hormone-sensitive prostate cancer, including active surveillance, brachytherapy, robotic prostatectomy, radiation therapy, HIFU, and other focal and multimodal approaches, with attention to surgical modifications, incontinence management, and updates in androgen deprivation therapy (ADT).
- Appraise the latest advances in diagnostics and imaging, including emerging biopsy techniques, PSMA-guided approaches, pre-biopsy markers, PTEN testing, and cutting-edge PET/MRI applications, to optimize diagnostic accuracy and clinical decision-making.
- Summarize current and evolving data on ADT, including strategies to manage side effects, enhance survivorship, and implement models for comprehensive patient care.
- Analyze the application of novel androgen pathway inhibitors, immunotherapies, PARP inhibitors, and radioligand therapy in treating hormone-sensitive and castration-resistant prostate cancer, along with the role of somatic testing upon progression.
- Discuss the status of ongoing clinical trials and their impact on developing innovative diagnostics and novel therapies.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Carden Jennings Publishing, Co., Ltd. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Below are the credit types that this activity is accredited for:
Physician Credit: Medical Education Resources designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit: Medical Education Resources designates this live activity for a maximum of 13.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 13.5 contact hours.
Physician Assistant Credit: Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.5 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.
Pharmacy Credit: Medical Education Resources (MER) designates this continuing education activity for 13.5 contact hours (1.45 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Program Number – JA 0003680-9999-26-062-L01-P)
This activity is certified as Knowledge based CPE.
Disclosure of All Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
Medical Education Resources and Carden Jennings Publishing, Co., Ltd jointly provide this activity.
This activity is supported by an educational grant from Blue Earth Diagnostics ($10,000) and Tolmar Pharmaceuticals ($5,000).
